Literature DB >> 18470541

[Etiology and pathophysiology of fibromyalgia syndrome and chronic widespread pain].

C Sommer1, W Häuser, K Gerhold, P Joraschky, F Petzke, T Tölle, N Uçeyler, A Winkelmann, K Thieme.   

Abstract

OBJECTIVE: To write a systematic review on the etiology and pathophysiology of the fibromyalgia syndrome (FMS) and of chronic widespread pain (CWP).
METHODS: An interdisciplinary level-3 guideline (i.e. systematic literature search and assessment, logic analysis, formal consensus procedure) for the diagnosis and therapy of FMS was created in cooperation with 10 medical and psychological societies and 2 patient self-help organizations. A literature search was performed covering all available review articles on the etiology and pathophysiology of FMS and CWP using the Cochrane Collaboration Reviews (1993-12/2006), Medline (1980-2006), PsychInfo (1966-12/2006), and Scopus (1980-12/2006). For the assignment of evidence classes the system of the Oxford Centre for Evidence-Based Medicine was applied. Consensus was achieved by a multi-step nominal group procedure.
RESULTS: FMS aggregates in families (evidence level 2c). Physical and psychological stress at the workplace are risk factors for the development of CWP and FMS. Affective disorders are risk factors for the development and maintenance of FMS. Operant learning mechanisms and sensitization are risk factors for the chronification of FMS (evidence levels 2b). Several factors are associated with the pathophysiology of FMS, but the causal relationship is unclear. This includes alterations of central pain pathways, hyporeactivity of the hypothalamus-pituitary-adrenal axis, increased systemic pro-inflammatory and reduced anti-inflammatory cytokine profiles and disturbances in the dopaminergic and serotonergic systems.
CONCLUSIONS: FMS is the common final product of various etiological factors and pathophysiological mechanisms.

Entities:  

Mesh:

Year:  2008        PMID: 18470541     DOI: 10.1007/s00482-008-0672-6

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  230 in total

1.  Orthostatic sympathetic derangement in subjects with fibromyalgia.

Authors:  M Martínez-Lavín; A G Hermosillo; C Mendoza; R Ortiz; J C Cajigas; C Pineda; A Nava; M Vallejo
Journal:  J Rheumatol       Date:  1997-04       Impact factor: 4.666

2.  Familial occurrence of primary fibromyalgia.

Authors:  M J Pellegrino; G W Waylonis; A Sommer
Journal:  Arch Phys Med Rehabil       Date:  1989-01       Impact factor: 3.966

3.  Cerebrospinal fluid corticotropin-releasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia.

Authors:  Samuel A McLean; David A Williams; Phyllis K Stein; Richard E Harris; Angela K Lyden; Gail Whalen; Karen M Park; Israel Liberzon; Ananda Sen; Richard H Gracely; James N Baraniuk; Daniel J Clauw
Journal:  Neuropsychopharmacology       Date:  2006-08-23       Impact factor: 7.853

4.  Altered interleukin-2 secretion in patients with primary fibromyalgia syndrome.

Authors:  N Hader; D Rimon; A Kinarty; N Lahat
Journal:  Arthritis Rheum       Date:  1991-07

5.  Widespread pain and Sjögren's syndrome.

Authors:  W T Pendarvis; S R Pillemer
Journal:  J Rheumatol       Date:  2001-12       Impact factor: 4.666

6.  Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome.

Authors:  Savaş Gürsoy; Emin Erdal; Hasan Herken; Ercan Madenci; Belgin Alaşehirli; Nurten Erdal
Journal:  Rheumatol Int       Date:  2002-10-22       Impact factor: 2.631

7.  Mutational analysis of serotonin receptor genes: HTR3A and HTR3B in fibromyalgia patients.

Authors:  Bernd Frank; Beate Niesler; Brigitta Bondy; Michael Späth; Dieter E Pongratz; Manfred Ackenheil; Christine Fischer; Gudrun Rappold
Journal:  Clin Rheumatol       Date:  2004-05-07       Impact factor: 2.980

8.  Regulation of the renin-angiotensin-aldosterone system in fibromyalgia.

Authors:  Anne M Maliszewski; Don L Goldenberg; Shelley Hurwitz; Gail K Adler
Journal:  J Rheumatol       Date:  2002-07       Impact factor: 4.666

9.  Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome.

Authors:  E N Griep; J W Boersma; E R de Kloet
Journal:  J Rheumatol       Date:  1993-03       Impact factor: 4.666

10.  Increased incidence of a resonance in the phosphodiester region of 31P nuclear magnetic resonance spectra in the skeletal muscle of fibromyalgia patients.

Authors:  S A Jubrias; R M Bennett; G A Klug
Journal:  Arthritis Rheum       Date:  1994-06
View more
  21 in total

1.  [Etiology and pathophysiology of fibromyalgia syndrome].

Authors:  C Sommer; W Häuser; M Burgmer; R Engelhardt; K Gerhold; F Petzke; T Schmidt-Wilcke; M Späth; T Tölle; N Uçeyler; H Wang; A Winkelmann; K Thieme
Journal:  Schmerz       Date:  2012-06       Impact factor: 1.107

2.  [Comorbid depression mediates the association of childhood/adolescent maltreatment and fibromyalgia syndrome. A study with patients from different clinical settings].

Authors:  M Kosseva; S Schild; R Wilhelm-Schwenk; W Biewer; W Häuser
Journal:  Schmerz       Date:  2010-09       Impact factor: 1.107

3.  [Risk minimization in pain therapy: important target but how can it be reached?].

Authors:  G-G Hanekop; F B M Ensink
Journal:  Schmerz       Date:  2008-10       Impact factor: 1.107

4.  [Visualization of a myth--the new S3 guidelines for fibromyalgia syndrome].

Authors:  B Widder
Journal:  Schmerz       Date:  2009-02       Impact factor: 1.107

Review 5.  Brain-derived neurotrophic factor and exercise in fibromyalgia syndrome patients: a mini review.

Authors:  Boya Nugraha; Matthias Karst; Stefan Engeli; Christoph Gutenbrunner
Journal:  Rheumatol Int       Date:  2011-12-31       Impact factor: 2.631

Review 6.  The hypothalamus: specific or nonspecific role in the pathophysiology of trigeminal autonomic cephalalgias?

Authors:  Dagny Holle; Zaza Katsarava; Mark Obermann
Journal:  Curr Pain Headache Rep       Date:  2011-04

Review 7.  [CNS processing of pain in functional somatic syndromes].

Authors:  F Petzke
Journal:  Schmerz       Date:  2010-04       Impact factor: 1.107

8.  Fibromyalgia syndrome: classification, diagnosis, and treatment.

Authors:  Winfried Häuser; Wolfgang Eich; Markus Herrmann; Detlev O Nutzinger; Marcus Schiltenwolf; Peter Henningsen
Journal:  Dtsch Arztebl Int       Date:  2009-06-05       Impact factor: 5.594

9.  [Somatoform disorders with pain as the predominant symptom: results to distinguish a common group of diseases].

Authors:  R Nickel; J Hardt; B Kappis; R Schwab; U T Egle
Journal:  Schmerz       Date:  2009-08       Impact factor: 1.107

Review 10.  Critical role of nociceptor plasticity in chronic pain.

Authors:  David B Reichling; Jon D Levine
Journal:  Trends Neurosci       Date:  2009-09-24       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.